Sustained release fluoride composition

Details Sustained release fluoride composition Sustained release fluoride composition

A - Human Necessities

61

K

167/292

A61K 33/42 (2006.01) A61K 9/20 (2006.01) A61K 9/26 (2006.01)

Patent

CA 1294551

SUSTAINED RELEASE FLUORIDE COMPOSITION ABSTRACT OF THE DISCLOSURE A medication for providing fluoride ion for the pre- vention and treatment of bone loss disease. The dosage is a lozenge, tablet or capsule containing from 20 to 100 milligrams of sodium monofluorophosphate and further includes a slow release mechanism for controlling release of the fluoride ion over a period of up to eight hours after swallowing. Up to ten percent of sodium fluoride can be added.

547354

Affiliated with

Also associated with

Rating

Sustained release fluoride composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sustained release fluoride composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release fluoride composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1341346